Guardion Announces Virtual Annual Meeting of Stockholders
September 11 2020 - 5:21PM
Guardion Health Sciences, Inc.(“Guardion” or the
“Company”) (NASDAQ: GHSI) announced that due to the public
health concerns related to COVID-19 and to support the health and
safety of its stockholders, employees and communities, it will
provide virtual attendance at its 2020 Annual Meeting of
Stockholders. The Company also filed definitive proxy materials
with the Securities and Exchange Commission in connection
with the Annual Meeting on September 8, 2020.
The Annual Meeting will be held on Thursday,
October 29, 2020, at 10:00 a.m. Pacific Time in a virtual format at
https://www.issuerdirect.com/virtual-event/ghsi.
Guardion stockholders as of the close of business
on September 1, 2020, are entitled to attend and to vote at
the Annual Meeting. On or about September 10, 2020, the
Company began mailing to each stockholder a Notice of Internet
Availability of Proxy Materials containing instructions on how to
access and review the proxy materials, including the proxy
statement and the Company’s annual report, on the internet and how
to access an electronic proxy card to vote. Due to restrictions and
guidelines on public gatherings issued by California authorities,
any record stockholder who wishes to attend the Annual Meeting may
only attend virtually.
There are four matters scheduled for a vote at
the Annual Meeting all as more fully described in the proxy
materials: (1) to elect five (5) members to the Company’s board of
directors; (2) to ratify the appointment of the Company’s
independent registered public accounting firm; (3) to approve an
amendment to the Company’s Equity Incentive Plan to increase the
number of shares issuable thereunder to 10,000,000 shares from
3,000,000 shares; and (4) to extend the previously-granted
discretionary authority of the Company’s board of directors to
amend the Company’s certificate of incorporation to effectuate a
“reverse stock split,” at a specific ratio within a range of no
split to a maximum of a one-for-thirty (1-for-30) split, from the
current authorization date of December 5, 2020 to within one year
of the date the new proposal is approved by stockholders, without
limiting the existing authority previously delegated to the board
of directors (the “Reverse Stock Split Proposal”).
In connection with the Reverse Stock Split
Proposal, the Company has until November 30, 2020 to regain
compliance with NASDAQ Listing Rule 5550(a)(2) regarding the
required minimum $1.00 bid price of its common stock. The Reverse
Stock Split Proposal would provide the board of directors
additional time to determine whether or not to implement a reverse
stock split to increase the per share price of the Company’s common
stock in order to regain compliance with the NASDAQ Rule.
The Company’s board of directors unanimously
recommends that stockholders vote "FOR" each of the proposals.
Whether or not stockholders plan to virtually
attend the Annual Meeting, we strongly urge you to vote and submit
your proxy in advance of the Annual Meeting by one of the methods
described in the Annual Meeting proxy materials. Further
information regarding virtual attendance and participation through
the online platform can be found in the Annual Meeting proxy
materials.
About Guardion Health Sciences, Inc.
Guardion is a specialty health sciences company
(i) that develops medical foods and medical devices in the ocular
health marketplace and (ii) that is developing nutraceuticals that
the Company believes will provide medicinal and health benefits to
consumers. Information and risk factors with respect to Guardion
and its business, including its ability to successfully develop and
commercialize its proprietary products and technologies, may be
obtained in the Company’s filings with the SEC
at www.sec.gov.
Forward-Looking Statement Disclaimer
With the exception of the historical information
contained in this news release, the matters described herein may
contain forward-looking statements within the meaning of Section
27A of the Securities Act of 1933, as amended, and Section 21E of
the Securities Exchange Act of 1934, as amended. Statements
preceded by, followed by or that otherwise include the words
“believes,” “expects,” “anticipates,” “intends,” “projects,”
“estimates,” “plans” and similar expressions or future or
conditional verbs such as “will,” “should,” “would,” “may” and
“could” are generally forward- looking in nature and not historical
facts, although not all forward-looking statements include the
foregoing. These statements involve unknown risks and uncertainties
that may individually or materially impact the matters discussed
herein for a variety of reasons that are outside the control of the
Company, including, but not limited to, the Company’s ability to
raise sufficient financing to implement its business plan, the
impact of the COVID-19 pandemic on the Company’s business,
operations and the economy in general, and the Company’s ability to
successfully develop and commercialize its proprietary products and
technologies. Readers are cautioned not to place undue reliance on
these forward- looking statements, as actual results could differ
materially from those described in the forward-looking statements
contained herein. Readers are urged to read the risk factors set
forth in the Company’s filings with the SEC, which are available at
the SEC’s website (www.sec.gov). The Company disclaims any
intention or obligation to update or revise any forward-looking
statements, whether as a result of new information, future events
or otherwise.
Investor Relations Contact:
MKR Investor Relations, Inc. Todd Kehrli
E-mail: ghsi@mkr-group.com
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Mar 2024 to Apr 2024
Guardion Health Sciences (NASDAQ:GHSI)
Historical Stock Chart
From Apr 2023 to Apr 2024